<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.0">
  <front>
    <journal-meta>
      <journal-id journal-id-type="pmc">PeerJ</journal-id>
      <journal-id journal-id-type="nlm-ta">PeerJ</journal-id>
      <journal-id journal-id-type="publisher-id">PeerJ</journal-id>
      <journal-title-group>
        <journal-title>PeerJ</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2167-8359</issn>
      <publisher>
        <publisher-name>PeerJ Inc.</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">66</article-id>
      <article-id pub-id-type="doi">10.7717/peerj.66</article-id>
      <article-categories>
        <subj-group subj-group-type="categories">
          <subject>Genetics</subject>
          <subject>Psychiatry and Psychology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Genome-wide association study of <italic>HLA-DQB1*06:02</italic> negative essential hypersomnia</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib id="author-1" contrib-type="author">
          <name>
            <surname>Khor</surname>
            <given-names>Seik-Soon</given-names>
          </name>
          <xref ref-type="aff" rid="aff-1">1</xref>
        </contrib>
        <contrib id="author-2" contrib-type="author" corresp="yes">
          <name>
            <surname>Miyagawa</surname>
            <given-names>Taku</given-names>
          </name>
          <xref ref-type="aff" rid="aff-1">1</xref>
          <email>miyagawa-taku@umin.ac.jp</email>
        </contrib>
        <contrib id="author-3" contrib-type="author">
          <name>
            <surname>Toyoda</surname>
            <given-names>Hiromi</given-names>
          </name>
          <xref ref-type="aff" rid="aff-1">1</xref>
        </contrib>
        <contrib id="author-4" contrib-type="author">
          <name>
            <surname>Yamasaki</surname>
            <given-names>Maria</given-names>
          </name>
          <xref ref-type="aff" rid="aff-1">1</xref>
        </contrib>
        <contrib id="author-5" contrib-type="author">
          <name>
            <surname>Kawamura</surname>
            <given-names>Yoshiya</given-names>
          </name>
          <xref ref-type="aff" rid="aff-2">2</xref>
        </contrib>
        <contrib id="author-6" contrib-type="author">
          <name>
            <surname>Tanii</surname>
            <given-names>Hisashi</given-names>
          </name>
          <xref ref-type="aff" rid="aff-3">3</xref>
        </contrib>
        <contrib id="author-7" contrib-type="author">
          <name>
            <surname>Okazaki</surname>
            <given-names>Yuji</given-names>
          </name>
          <xref ref-type="aff" rid="aff-4">4</xref>
        </contrib>
        <contrib id="author-8" contrib-type="author">
          <name>
            <surname>Sasaki</surname>
            <given-names>Tsukasa</given-names>
          </name>
          <xref ref-type="aff" rid="aff-5">5</xref>
        </contrib>
        <contrib id="author-9" contrib-type="author">
          <name>
            <surname>Lin</surname>
            <given-names>Ling</given-names>
          </name>
          <xref ref-type="aff" rid="aff-6">6</xref>
        </contrib>
        <contrib id="author-10" contrib-type="author">
          <name>
            <surname>Faraco</surname>
            <given-names>Juliette</given-names>
          </name>
          <xref ref-type="aff" rid="aff-6">6</xref>
        </contrib>
        <contrib id="author-11" contrib-type="author">
          <name>
            <surname>Rico</surname>
            <given-names>Tom</given-names>
          </name>
          <xref ref-type="aff" rid="aff-6">6</xref>
        </contrib>
        <contrib id="author-12" contrib-type="author" deceased="yes">
          <name>
            <surname>Honda</surname>
            <given-names>Yutaka</given-names>
          </name>
          <xref ref-type="aff" rid="aff-7">7</xref>
        </contrib>
        <contrib id="author-13" contrib-type="author">
          <name>
            <surname>Honda</surname>
            <given-names>Makoto</given-names>
          </name>
          <xref ref-type="aff" rid="aff-7">7</xref>
          <xref ref-type="aff" rid="aff-8">8</xref>
        </contrib>
        <contrib id="author-14" contrib-type="author">
          <name>
            <surname>Mignot</surname>
            <given-names>Emmanuel</given-names>
          </name>
          <xref ref-type="aff" rid="aff-6">6</xref>
        </contrib>
        <contrib id="author-15" contrib-type="author">
          <name>
            <surname>Tokunaga</surname>
            <given-names>Katsushi</given-names>
          </name>
          <xref ref-type="aff" rid="aff-1">1</xref>
        </contrib>
        <aff id="aff-1"><label>1</label><institution>Department of Human Genetics, Graduate School of Medicine, The University of Tokyo</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country></aff>
        <aff id="aff-2"><label>2</label><institution>Yokohama Clinic, Warakukai Medical Corporation</institution>, <addr-line>Yokohama</addr-line>, <country>Japan</country></aff>
        <aff id="aff-3"><label>3</label><institution>Department of Psychiatry, Mie University School of Medicine</institution>, <addr-line>Mie</addr-line>, <country>Japan</country></aff>
        <aff id="aff-4"><label>4</label><institution>Metropolitan Matsuzawa Hospital</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country></aff>
        <aff id="aff-5"><label>5</label><institution>Graduate School of Education, The University of Tokyo</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country></aff>
        <aff id="aff-6"><label>6</label><institution>Stanford Center for Sleep Sciences and Medicine, Stanford University School of Medicine</institution>, <addr-line>Palo Alto, CA</addr-line>, <country>USA</country></aff>
        <aff id="aff-7"><label>7</label><institution>Department of Somnology, Tokyo Medical University</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country></aff>
        <aff id="aff-8"><label>8</label><institution>Sleep Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science</institution>, <addr-line>Tokyo</addr-line>, <country>Japan</country></aff>
      </contrib-group>
      <contrib-group content-type="editors">
        <contrib id="editor-1" contrib-type="editor">
          <name>
            <surname>Crandall</surname>
            <given-names>Keith</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" date-type="pub" iso-8601-date="2013-04-16">
        <day>16</day>
        <month>4</month>
        <year iso-8601-date="2013">2013</year>
      </pub-date>
      <volume>1</volume>
      <elocation-id>e66</elocation-id>
      <history>
        <date date-type="received" iso-8601-date="2013-01-23">
          <day>23</day>
          <month>1</month>
          <year iso-8601-date="2013">2013</year>
        </date>
        <date date-type="accepted" iso-8601-date="2013-03-20">
          <day>20</day>
          <month>3</month>
          <year iso-8601-date="2013">2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2013 Khor et al.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Khor et al.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://peerj.com/articles/66"/>
      <abstract>
        <p>Essential hypersomnia (EHS), a sleep disorder characterized by excessive daytime sleepiness, can be divided into two broad classes based on the presence or absence of the <italic>HLA-DQB1*06:02</italic> allele. <italic>HLA-DQB1*06:02</italic>-positive EHS and narcolepsy with cataplexy are associated with the same susceptibility genes. In contrast, there are fewer studies of <italic>HLA-DQB1*06:02</italic> negative EHS which, we hypothesized, involves a different pathophysiological pathway than does narcolepsy with cataplexy. In order to identify susceptibility genes associated with <italic>HLA-DQB1*06:02</italic> negative EHS, we conducted a genome-wide association study (GWAS) of 125 unrelated Japanese EHS patients lacking the <italic>HLA-DQB1*06:02</italic> allele and 562 Japanese healthy controls. A comparative study was also performed on 268 <italic>HLA-DQB1*06:02</italic> negative Caucasian hypersomnia patients and 1761 <italic>HLA-DQB1*06:02</italic> negative Caucasian healthy controls. We identified three SNPs that each represented a unique locus— rs16826005 (<italic>P</italic> = 1.02E-07; <italic>NCKAP5</italic>), rs11854769 (<italic>P</italic> = 6.69E-07; <italic>SPRED1</italic>), and rs10988217 (<italic>P</italic> = 3.43E-06; <italic>CRAT</italic>) that were associated with an increased risk of EHS in this Japanese population. Interestingly, rs10988217 showed a similar tendency in its association with both <italic>HLA-DQB1*06:02</italic> negative EHS and narcolepsy with cataplexy in both Japanese and Caucasian populations. This is the first GWAS of <italic>HLA-DQB1*06:02</italic> negative EHS, and the identification of these three new susceptibility loci should provide additional insights to the pathophysiological pathway of this condition.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>
          <italic>SPRED1</italic>
        </kwd>
        <kwd>Essential hypersomnia</kwd>
        <kwd>
          <italic>NAP5</italic>
        </kwd>
        <kwd>
          <italic>NCKAP5</italic>
        </kwd>
        <kwd>
          <italic>CRAT</italic>
        </kwd>
        <kwd>
          <italic>HLA-DQB1*06:02</italic>
        </kwd>
        <kwd>Narcolepsy with cataplexy</kwd>
        <kwd>Narcolepsy</kwd>
        <kwd>EHS</kwd>
      </kwd-group>
      <funding-group>
        <award-group id="fund-1">
          <funding-source>The Ministry of Education, Culture, Sports, Science and Technology of Japan</funding-source>
          <award-id>Grants-in-Aid for Young Scientists (A) (23689022)</award-id>
          <award-id>Scientific Research on Innovative Areas (22133008)</award-id>
        </award-group>
        <award-group id="fund-2">
          <funding-source>Takeda Science Foundation</funding-source>
        </award-group>
        <award-group id="fund-3">
          <funding-source>SENSHIN Medical Research Foundation</funding-source>
        </award-group>
        <funding-statement>This study was supported by Grants-in-Aid for Young Scientists (A) (23689022) and Scientific Research on Innovative Areas (22133008) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and Grants-in-Aid from “Takeda Science Foundation” and “SENSHIN Medical Research Foundation”. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p>Hypersomnias are one of the important classes of sleep disorders, patients are manifested by recurring episodes of excessive daytime sleepiness (EDS) that are not due to tiredness. Hypersomnia can be a symptom of other sleep disorders such as narcolepsy with cataplexy, essential hypersomnia (EHS), sleep apnea and idiopathic hypersomnia.</p>
      <p>In 1986, Yutaka Honda described a group of patients with a narcolepsy-like condition that lacked cataplexy; he designated this condition essential hypersomnia syndrome (EHS) (<xref ref-type="bibr" rid="ref-16">Honda et al., 1986</xref>). EHS is characterized by excessive daytime sleepiness features that are indistinguishable from those of narcolepsy such as shorter episodes of irresistible daytime sleepiness, feelings of refreshment after short naps, and the absence of prolonged nocturnal sleep time. Patients with EHS show frequent sleep-onset rapid eye movement (REM) periods (SOREMPs) when a multiple sleep latency test (MSLT) is performed (<xref ref-type="bibr" rid="ref-1">2001</xref>). Honda and his colleagues later reported that the symptomatic characteristics of these patients are different from those of patients with classical idiopathic hypersomnia syndrome (IHS); reportedly, IHS sleep patterns include long naps and prolonged nocturnal sleep (<xref ref-type="bibr" rid="ref-33">Roth, 1976</xref>). Based on the criteria in the International Classification of Sleep Disorders second edition (ICSD-2) (<xref ref-type="bibr" rid="ref-2">American Academy of Sleep Medicine, 2005</xref>), the diagnostic criteria for EHS correspond to those for narcolepsy without cataplexy and most of those for IHS without long sleep. Previously we showed that approximately 40% of the patients with EHS carry the <italic>HLA-DQB1*06:02</italic> allele but that 12% of the general Japanese population and 100% of the patients with narcolepsy with cataplexy carry this allele (<xref ref-type="bibr" rid="ref-29">Mukai et al., 2003</xref>; <xref ref-type="bibr" rid="ref-23">Miyagawa et al., 2009</xref>). Additionally several reports from other groups also indicate that <italic>HLA-DQB1*06:02</italic> is associated with the pathogenesis of narcolepsy with cataplexy (<xref ref-type="bibr" rid="ref-22">Mignot et al., 2001</xref>; <xref ref-type="bibr" rid="ref-17">Juji et al., 1984</xref>; <xref ref-type="bibr" rid="ref-21">Marcadet et al., 1985</xref>); given these finding, we believe that the pathogenesis of EHS may partially differ from that of narcolepsy with cataplexy. In addition, study has also suggested that EHS is likely to be a member of hypersomnia based on the differences in genetic composition of EHS and narcolepsy with cataplexy, milder disease severity of EHS, and the superior treatment response of EHS (<xref ref-type="bibr" rid="ref-29">Mukai et al., 2003</xref>). Based on Epworth Sleepiness Scale (ESS) and MSLT evaluations, the severity of EDS is significantly milder in EHS than in narcolepsy with cataplexy (<xref ref-type="bibr" rid="ref-18">Komada et al., 2005</xref>).</p>
      <p>Several studies carried out by our group demonstrate that common susceptibility genes exist between <italic>HLA-DQB1*06:02</italic> positive EHS and narcolepsy with cataplexy patients, suggesting a common etiological pathway might exist for <italic>HLA-DQB1*06:02</italic> positive EHS and narcolepsy with cataplexy patients. For example, <italic>TCRA</italic> is reported to be strongly associated with narcolepsy with cataplexy (<xref ref-type="bibr" rid="ref-14">Hallmayer et al., 2009</xref>) and our replication study indicated that <italic>TCRA</italic> is also associated with <italic>HLA-DQB1*06:02</italic> positive EHS (<xref ref-type="bibr" rid="ref-24">Miyagawa et al., 2010</xref>). In contrast, <italic>CPT1B</italic> and <italic>CHKB</italic>, which are reportedly associated with narcolepsy with cataplexy in a Japanese population (<xref ref-type="bibr" rid="ref-26">Miyagawa et al., 2008</xref>), are also reportedly associated with both <italic>HLA-DQB1*06:02</italic>-positive EHS and EHS in patients lacking <italic>HLA-DQB1*06:02</italic> (designated here as <italic>HLA-DQB1*06:02</italic>-negative EHS) (<xref ref-type="bibr" rid="ref-23">Miyagawa et al., 2009</xref>). Taken together these findings indicate that <italic>CPT1B</italic> and <italic>CHKB</italic> have a broader functional role in hypersomnias as general.</p>
      <p>Based on the hypothesis that <italic>HLA-DQB1*06:02</italic> negative EHS has a different etiological pathway from that of narcolepsy with cataplexy, we aimed to identify commonly occurring genetic variants that are associated with susceptibility to <italic>HLA-DQB1*06:02</italic> negative EHS in a Japanese study population. To our knowledge, there is no published report of a genome-wide association study (GWAS) on any hypersomnia in any human population other than those GWASs on narcolepsy with cataplexy.</p>
    </sec>
    <sec sec-type="methods">
      <title>Materials and Methods</title>
      <sec>
        <title>Subjects</title>
        <p>EHS was diagnosed based on the following three clinical items in central nervous system hypersomnias: (i) recurrent daytime sleep episodes that occur basically everyday over a period of at least 6 months; (ii) absence of cataplexy; (iii) the hypersomnia is not better explained by another sleep disorder, medical or neurological disorder, mental disorder, medication use or substance use disorder (<xref ref-type="bibr" rid="ref-29">Mukai et al., 2003</xref>; <xref ref-type="bibr" rid="ref-18">Komada et al., 2005</xref>; <xref ref-type="bibr" rid="ref-23">Miyagawa et al., 2009</xref>; <xref ref-type="bibr" rid="ref-16">Honda et al., 1986</xref>). We focused our studies on patient with EHS, but lacking <italic>HLA-DQB1*06:02</italic>, because previous studies (<xref ref-type="bibr" rid="ref-24">Miyagawa et al., 2010</xref>; <xref ref-type="bibr" rid="ref-16">Honda et al., 1986</xref>; <xref ref-type="bibr" rid="ref-29">Mukai et al., 2003</xref>) indicated that <italic>HLA-DQB1*06:02</italic> negative EHS is essentially different from HLA-positive EHS and narcolepsy with cataplexy. In this GWAS, we recruited 125 individuals who were given a diagnosis of EHS at a clinic affiliated with Neuropsychiatric Research Institute of Japan and 562 Japanese individuals as healthy controls. All genomic DNA samples were genotyped using Affymetrix Genome-Wide SNP Array 6.0 platform. In order to validate the accuracy of the top SNPs from the Affymetrix Genome-Wide SNP Array 6.0 platform, three SNPs (rs11854769, rs12471007 and rs10988217) were genotyped by TaqMan assay.</p>
        <p>In order to elucidate the effects of susceptibility SNPs found in Japanese EHS GWAS samples in other population, a collaboration study with the Center for Narcolepsy, Stanford University School of Medicine, was carried out. The comparative study of a Caucasian population focused on patients with 268 <italic>HLA-DQB1*06:02</italic>-negative hypersomnias and 1761 <italic>HLA-DQB1*06:02</italic>-negative healthy controls. All subjects had given written informed consent for their participation in these studies in accordance with the process approved by ethics committees of the University of Tokyo and Stanford University.</p>
      </sec>
      <sec>
        <title>HLA genotyping</title>
        <p><italic>HLA-DQB1</italic> genotyping for EHS samples were performed using Luminex Multi-Analyte Profiling System (xMAP) together with the WAKFlow HLA typing kit (Wakunaga, Hiroshima, Japan). Briefly, target DNA was amplified by PCR (polymerase chain reaction) with biotinylated primers. The PCR amplicon was then denatured and hybridized to complementary oligonucleotide probes immobilized on fluorescent coded microsphere beads. In the meantime, biotinylated PCR products were labeled with phycoerythrin-conjugated streptavidin, and finally HLA typing was examined by Luminex 100 (Luminex, Austin, TX).</p>
      </sec>
      <sec>
        <title>Genotyping and quality control</title>
        <p>Genotype calling was performed using Affymetrix Genotyping Console 4.0, which employs the Birdseed genotype calling algorithm for Affy 6.0 (<italic>n</italic> = 687). Samples with a low quality control call rate (typically &lt;95%) were excluded before performing the full clustering analysis of genotypes. For each Birdseed genotype call, SNPs with call rates &lt;99%, SNP that shown deviation from Hardy-Weinberg (<italic>P</italic> &lt; 0.001) in controls, monomorphic SNP, and sex-chromosome SNPs were excluded from subsequent analysis. Cluster plots of the top 100 SNPs that showed the strongest association were checked visually and ambiguously clustered SNPs were excluded; only one SNP was excluded based on this cluster criterion. In the absent of independent Japanese EHS samples for replication, we validated the accuracy of randomly selected SNPs genotyped by Affymetrix 6.0 platform using a TaqMan assay.</p>
      </sec>
      <sec>
        <title>Statistical analysis</title>
        <p>Association analysis of SNPs were analyzed using an allelic model, a dominant model, a recessive model, or a Cochran–Armitage trend test using PLINK (v1.07) (<xref ref-type="bibr" rid="ref-32">Purcell et al., 2007</xref>). Population stratification within the Japanese patients with EHS was evaluated based on the genomic inflation factor (λ), which was calculated from the median of the Cochran–Armitage trend test. The quantile-quantile (Q–Q) plot was plotted with expected distribution of association test statistics under null distribution across the Cochran–Armitage trend observed <italic>P</italic>-values with <italic>R</italic> statistical environment version 2.9.0. Peta odd ratio was used to calculate odd ratio for any contingency column with counting of 0, online calculator is available at <uri xlink:href="http://www.hutchon.net/ConfidORnulhypo.htm">http://www.hutchon.net/ConfidORnulhypo.htm</uri>. Manhattan-plot was generated using Haploview (v4.1) (<xref ref-type="bibr" rid="ref-4">Barrett et al., 2005</xref>). For the Caucasian comparative study, an allelic, a dominant, and a recessive model were each assessed using a 2-tailed chi-square test. The eQTL analyses were performed based on data from the Sanger Institute GENEVAR project (<xref ref-type="bibr" rid="ref-38">Yang et al., 2010</xref>); these data are based on three cell types (fibroblast, lymphoblastoid cell line and T-cell) of 75 unrelated Western European origin individuals (<xref ref-type="bibr" rid="ref-11">Dimas et al., 2009</xref>). The SNPExpress Database (<xref ref-type="bibr" rid="ref-15">Heinzen et al., 2008</xref>), which is based on 93 autopsy-collected cortical brain tissue with no defined neuropsychiatric condition and 80 peripheral blood mononucleated cell (PMBC) samples collected from healthy donors, was also used as a reference for eQTL analyses. Relationships between the genotypes of candidate loci and the expression levels of nearby genes and transcripts were also examined.</p>
      </sec>
      <sec>
        <title>Imputation</title>
        <p>MACH version 1.0 (<xref ref-type="bibr" rid="ref-20">Li et al., 2010</xref>) was used to estimate haplotypes, map crossover and error rates using 50 iterations of the Markov chain Monte Carlo algorithm. By employing genotype information from HapMap Phase II (release 23) database (<xref ref-type="bibr" rid="ref-10">International Hapmap Consortium, 2005</xref>), maximum likelihood genotypes were generated. For the quality control of the imputed genotypes, imputed genotypes with the estimated <italic>r</italic>2 &gt; 0.3 were retained. Imputed genotypes were re-analyzed by allelic, dominant, and recessive models and the Cochran–Armitage trend test utilizing PLINK 1.7. Regional association plots were generated using LocusZoom (<xref ref-type="bibr" rid="ref-31">Pruim et al., 2010</xref>).</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <p>This is the first reported GWAS that aimed to identify common genetic variants associated with <italic>HLA-DQB1*06:02</italic> negative EHS. Specifically, we sought to identify susceptibility loci, other than HLA loci, for EHS using a collection of samples that lacking the <italic>HLA- DQB1*06:02</italic>. For this GWAS, we recruited 125 individuals who were given a diagnosis of EHS at a clinic that is affiliated with the Neuropsychiatric Research Institute of Japan and 562 Japanese healthy controls. Genomic DNA samples from each individual were genotyped using the Affymetrix Genome-Wide SNP Array 6.0 platform. After quality controls (see Methods for details), statistical tests were performed on 508,366 remaining SNPs. Population stratification was accessed by calculating the genomic inflation factor (λ); the λ of this data set was 1.008; this finding indicated that errors resulting from population stratification, cryptic relatedness, or both were unlikely (<xref ref-type="supplementary-material" rid="supp-1">Fig. S1</xref>). A genome-wide Manhattan plot was drawn using the chromosomal positions of individual SNPs (<italic>x</italic>-axis) and the negative logarithm of <italic>P</italic> values calculated with the Cochran–Armitage trend test (<italic>y</italic>-axis) (<xref ref-type="supplementary-material" rid="supp-2">Fig. S2</xref>).</p>
      <p>We identified one genomic region, 2q21.2, that contained clustered SNPs that were significantly associated (<italic>P</italic>-value &lt; 5 × 10<sup>−7</sup>) with increased risk of EHS in this Japanese population (<xref ref-type="supplementary-material" rid="supp-2">Fig. S2</xref> and <xref ref-type="table" rid="table-1">Table 1</xref>). Additionally, we chose to further investigate 9q34 because of its functional importance.</p>
      <p>The SNP rs16826005 had the lowest <italic>P</italic>-value (1.02E-07, per-allele odds ratio (OR) of 1.89 with 95% confidence interval (CI) of 1.43–2.50) of all SNPs assessed; rs16826005 was located within a 19-kb linkage disequilibrium (LD) block on chromosome 2q21.2 (<xref ref-type="table" rid="table-1">Table 1</xref>). This LD-block covered the intronic region of <italic>NCKAP5</italic> (NCK-associated protein 5) gene. Imputation analysis of this region revealed modest associations between <italic>HLA-DQB1*06:02</italic> negative EHS and SNPs in the <italic>NCKAP5</italic> gene. This finding indicated that <italic>NCKAP5</italic> may play a causative role in EHS pathogenesis. Expression data for <italic>NCKAP5</italic> is not readily available in the Gene Variation Database (GeneVar) (<xref ref-type="bibr" rid="ref-38">Yang et al., 2010</xref>) or the SNPExpress database (<xref ref-type="bibr" rid="ref-15">Heinzen et al., 2008</xref>).</p>
      <table-wrap id="table-1">
        <object-id pub-id-type="doi">10.7717/peerj.66/table-1</object-id>
        <label>Table 1</label>
        <caption>
          <title>List of SNPs that show associations with increase risk of <italic>HLA-DQB1*06:02</italic> negative EHS in the Japanese population.</title>
        </caption>
        <alternatives>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/66/table-1.png"/>
          <table>
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">CHR</th>
                <th align="left">SNP</th>
                <th align="center">Risk</th>
                <th align="center" colspan="2">RAF</th>
                <th align="center" colspan="4">Allelic</th>
                <th align="center" colspan="4">Dominant</th>
                <th align="center" colspan="4">Recessive</th>
                <th align="center">
                  <italic>P</italic>
                  <sub>min</sub>
                </th>
                <th align="left">Nearby Gene</th>
              </tr>
              <tr>
                <th align="left"/>
                <th align="left"/>
                <th align="left">Allele</th>
                <th align="left">Case</th>
                <th align="left">Control</th>
                <th align="left"><italic>P</italic>-values</th>
                <th align="left">OR</th>
                <th align="left">L95</th>
                <th align="left">U95</th>
                <th align="left"><italic>P</italic>-values</th>
                <th align="left">OR</th>
                <th align="left">L95</th>
                <th align="left">U95</th>
                <th align="left"><italic>P</italic>-values</th>
                <th align="left">OR</th>
                <th align="left">L95</th>
                <th align="left">U95</th>
                <th align="left"/>
                <th align="left"/>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">2</td>
                <td align="left">rs16826005</td>
                <td align="left">G</td>
                <td align="left">0.472</td>
                <td align="left">0.319</td>
                <td align="left">3.97E-06</td>
                <td align="left">1.89</td>
                <td align="left">1.43</td>
                <td align="left">2.50</td>
                <td align="left">7.51E-03</td>
                <td align="left">1.74</td>
                <td align="left">1.16</td>
                <td align="left">2.62</td>
                <td align="left">1.02E-07</td>
                <td align="left">3.52</td>
                <td align="left">2.17</td>
                <td align="left">5.70</td>
                <td align="left">1.02E-07</td>
                <td align="left">
                  <italic>NCKAP5</italic>
                </td>
              </tr>
              <tr>
                <td align="left">2</td>
                <td align="left">rs12471007<xref ref-type="fn" rid="table-1fn4"><sup>*</sup></xref>
                           <xref ref-type="fn" rid="table-1fn5"><sup>#</sup></xref>
                        </td>
                <td align="left">C</td>
                <td align="left">0.456</td>
                <td align="left">0.312</td>
                <td align="left">1.33E-05</td>
                <td align="left">1.86</td>
                <td align="left">1.41</td>
                <td align="left">2.46</td>
                <td align="left">1.86E-02</td>
                <td align="left">1.72</td>
                <td align="left">1.15</td>
                <td align="left">2.56</td>
                <td align="left">1.09E-07</td>
                <td align="left">4.11</td>
                <td align="left">2.55</td>
                <td align="left">6.60</td>
                <td align="left">1.09E-07</td>
                <td align="left">
                  <italic>NCKAP5</italic>
                </td>
              </tr>
              <tr>
                <td align="left">15</td>
                <td align="left">rs11854769<xref ref-type="fn" rid="table-1fn4"><sup>*</sup></xref>
                        </td>
                <td align="left">T</td>
                <td align="left">0.316</td>
                <td align="left">0.177</td>
                <td align="left">6.69E-07</td>
                <td align="left">2.27</td>
                <td align="left">1.64</td>
                <td align="left">3.14</td>
                <td align="left">7.15E-06</td>
                <td align="left">2.43</td>
                <td align="left">1.64</td>
                <td align="left">3.59</td>
                <td align="left">3.61E-04</td>
                <td align="left">4.07</td>
                <td align="left">1.78</td>
                <td align="left">9.31</td>
                <td align="left">6.69E-07</td>
                <td align="left">
                  <italic>SPRED1</italic>
                </td>
              </tr>
              <tr>
                <td align="left">15</td>
                <td align="left">rs2174009</td>
                <td align="left">C</td>
                <td align="left">0.335</td>
                <td align="left">0.193</td>
                <td align="left">9.34E-07</td>
                <td align="left">2.24</td>
                <td align="left">1.62</td>
                <td align="left">3.10</td>
                <td align="left">1.02E-05</td>
                <td align="left">2.40</td>
                <td align="left">1.62</td>
                <td align="left">3.56</td>
                <td align="left">2.87E-04</td>
                <td align="left">3.90</td>
                <td align="left">1.78</td>
                <td align="left">8.56</td>
                <td align="left">9.34E-07</td>
                <td align="left">
                  <italic>SPRED1</italic>
                </td>
              </tr>
              <tr>
                <td align="left">15</td>
                <td align="left">rs16966389</td>
                <td align="left">G</td>
                <td align="left">0.804</td>
                <td align="left">0.642</td>
                <td align="left">7.52E-07</td>
                <td align="left">2.28</td>
                <td align="left">1.63</td>
                <td align="left">3.20</td>
                <td align="left">6.56E-07</td>
                <td align="left">2.73</td>
                <td align="left">1.82</td>
                <td align="left">4.10</td>
                <td align="left">1.07E-02</td>
                <td align="left">2.91</td>
                <td align="left">1.24</td>
                <td align="left">6.86</td>
                <td align="left">6.56E-07</td>
                <td align="left">
                  <italic>SPRED1</italic>
                </td>
              </tr>
              <tr>
                <td align="left">2</td>
                <td align="left">rs359268</td>
                <td align="left">C</td>
                <td align="left">0.584</td>
                <td align="left">0.431</td>
                <td align="left">1.16E-05</td>
                <td align="left">1.89</td>
                <td align="left">1.42</td>
                <td align="left">2.51</td>
                <td align="left">1.47E-02</td>
                <td align="left">1.79</td>
                <td align="left">1.12</td>
                <td align="left">2.88</td>
                <td align="left">1.00E-06</td>
                <td align="left">2.81</td>
                <td align="left">1.84</td>
                <td align="left">4.30</td>
                <td align="left">1.00E-06</td>
                <td align="left">
                  <italic>BCL11A</italic>
                </td>
              </tr>
              <tr>
                <td align="left">15</td>
                <td align="left">rs2134333</td>
                <td align="left">A</td>
                <td align="left">0.332</td>
                <td align="left">0.194</td>
                <td align="left">1.99E-06</td>
                <td align="left">2.19</td>
                <td align="left">1.58</td>
                <td align="left">3.02</td>
                <td align="left">2.05E-05</td>
                <td align="left">2.32</td>
                <td align="left">1.57</td>
                <td align="left">3.44</td>
                <td align="left">3.52E-04</td>
                <td align="left">3.83</td>
                <td align="left">1.75</td>
                <td align="left">8.40</td>
                <td align="left">1.99E-06</td>
                <td align="left">
                  <italic>SPRED1</italic>
                </td>
              </tr>
              <tr>
                <td align="left">5</td>
                <td align="left">rs7725217</td>
                <td align="left">C</td>
                <td align="left">0.352</td>
                <td align="left">0.223</td>
                <td align="left">1.96E-05</td>
                <td align="left">2.00</td>
                <td align="left">1.46</td>
                <td align="left">2.74</td>
                <td align="left">1.08E-06</td>
                <td align="left">2.66</td>
                <td align="left">1.78</td>
                <td align="left">3.98</td>
                <td align="left">4.08E-01</td>
                <td align="left">1.41</td>
                <td align="left">0.62</td>
                <td align="left">3.19</td>
                <td align="left">1.08E-06</td>
                <td align="left">
                  <italic>TAS2R1</italic>
                </td>
              </tr>
              <tr>
                <td align="left">9</td>
                <td align="left">rs10988217<xref ref-type="fn" rid="table-1fn4"><sup>*</sup></xref>
                        </td>
                <td align="left">G</td>
                <td align="left">0.320</td>
                <td align="left">0.233</td>
                <td align="left">4.05E-03</td>
                <td align="left">1.52</td>
                <td align="left">1.13</td>
                <td align="left">2.04</td>
                <td align="left">2.55E-01</td>
                <td align="left">1.25</td>
                <td align="left">0.85</td>
                <td align="left">1.85</td>
                <td align="left">3.43E-06</td>
                <td align="left">3.85</td>
                <td align="left">2.11</td>
                <td align="left">7.04</td>
                <td align="left">3.43E-06</td>
                <td align="left">
                  <italic>PPP2R4/CRAT</italic>
                </td>
              </tr>
              <tr>
                <td align="left">2</td>
                <td align="left">rs2043234</td>
                <td align="left">T</td>
                <td align="left">0.359</td>
                <td align="left">0.224</td>
                <td align="left">8.22E-06</td>
                <td align="left">1.95</td>
                <td align="left">1.45</td>
                <td align="left">2.64</td>
                <td align="left">1.15E-03</td>
                <td align="left">1.91</td>
                <td align="left">1.29</td>
                <td align="left">2.83</td>
                <td align="left">4.46E-06</td>
                <td align="left">4.05</td>
                <td align="left">2.14</td>
                <td align="left">7.66</td>
                <td align="left">4.46E-06</td>
                <td align="left">
                  <italic>NCKAP5</italic>
                </td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="table-1fn">
            <p>
              <bold>Notes.</bold>
            </p>
          </fn>
          <fn id="table-1fn1" fn-type="other">
            <p>RAF, risk allele frequency; OR, odd ratio; L95, U95, lower and upper confidence limits; <italic>P</italic><sub>min</sub>, minimum <italic>P</italic>-value among three genetic models; NA: not applicable.</p>
          </fn>
          <fn id="table-1fn2" fn-type="other">
            <p>Recessive model is calculated under risk allele homozygotes versus (heterozygous and non-risk homozygotes).</p>
          </fn>
          <fn id="table-1fn3" fn-type="other">
            <p>Dominant model is calculated under (risk allele homozygotes and heterozygotes) versus non-risk homozygotes.</p>
          </fn>
          <fn id="table-1fn4">
            <label>*</label>
            <p>SNP count was reconfirmed by TaqMan platform.</p>
          </fn>
          <fn id="table-1fn5">
            <label>#</label>
            <p>SNP count adjusted for TaqMan platform.</p>
          </fn>
          <fn id="table-1fn6" fn-type="other">
            <p>Peta odd ratio was used to calculate odd ratio for any contingency column with counting of 0.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>The SNP rs11854769 had the second lowest <italic>P</italic>-value by regional classification (6.69E-07, per-allele OR of 2.27 with 95% CI of 1.64–3.14) in this analysis. This SNP, rs11854769, resided within a 10 kb LD block on chromosome 15q14 (<xref ref-type="table" rid="table-1">Table 1</xref>) and was located 42 kb upstream of <italic>SPRED1</italic> (<italic>sprouty-related, EVH1 domain containing 1</italic>). Imputation analysis of this region did not reveal any additional SNPs that were more significantly associated with <italic>HLA-DQB1*06:02</italic> negative EHS (<xref ref-type="fig" rid="fig-1">Fig. 1</xref>). An eQTL analysis showed that rs11854769 did not affect the expression level of <italic>SPRED1</italic> in either the GeneVar database or the SNPExpress database (<xref ref-type="supplementary-material" rid="supp-4">Fig. S4A</xref>).</p>
      <fig id="fig-1">
        <object-id pub-id-type="doi">10.7717/peerj.66/fig-1</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Regional association plots for three <italic>HLA-DQB1*06:02</italic> negative EHS risk loci.</title>
          <p>(A) The region 2q21.2 Cochran–Armitage trend test <italic>P</italic>-value, the SNP rs16826003 is located in an intron of <italic>NCKAP5</italic> gene (B) The region 15q14 Cochran–Armitage trend test, SNP rs11854769 is located 42 kb upstream of the nearest gene, <italic>SPRED1</italic> (C) The 9q34 region based on P-minimum, rs10988217 is located in an intron of <italic>CRAT</italic> gene. Each of the top markers is indicated by purple diamonds. SNPs that were genotyped using Affymetrix 6.0 are marked by triangles. Imputed SNPs are plotted as circles. The color intensity represents the extent of the LD with the marker SNP, red (<italic>r</italic><sup>2</sup> ≥ 0.8), orange (0.6 ≤ 0.8), green (0.4 ≤ 0.6), light blue (0.2 ≤ 0.4), and dark blue (<italic>r</italic><sup>2</sup> ≤ 0.2). Light blue in the background indicates local recombination rate.</p>
        </caption>
        <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/66/fig-1.png"/>
      </fig>
      <p>The SNP rs10988217 (<italic>P</italic>-value of 3.43E-06, per-allele OR of 1.52 with 95% CI of 1.13–2.04), which was located within a 63 kb LD block on chromosome 9q34.11, was also of interest (<xref ref-type="table" rid="table-1">Table 1</xref>). The associated SNP is located in the intronic region of <italic>PPP2R4</italic> (protein phosphatase 2A activator, regulatory subunit 4) and <italic>CRAT</italic> (carnitine O-acetyltransferase).The eQTL analysis revealed that rs10988217 affected the expression of <italic>CRAT</italic> transcripts in the SNPExpress database (<xref ref-type="supplementary-material" rid="supp-4">Fig. S4B</xref>), but not <italic>PPP2R4</italic> transcripts (<xref ref-type="supplementary-material" rid="supp-4">Fig. S4C</xref>). Similar findings were observed in the GeneVar database; rs10988217 was associated with <italic>CRAT</italic> expression levels (<italic>P</italic> &lt; 0.05) in three cell types (fibroblast, lymphoblastoid cell line and T-cell) (<xref ref-type="supplementary-material" rid="supp-3">Fig. S3B</xref>), but not with any changes in <italic>PPP2R4</italic> expression (<xref ref-type="supplementary-material" rid="supp-3">Fig. S3C</xref>).</p>
      <p>A comparative study of Caucasian patients with <italic>HLA-DQB1*06:02</italic> negative hypersomnia revealed that rs10988217, the SNP in the <italic>PPP2R4</italic>-<italic>CRAT</italic> region, was significantly associated with <italic>HLA-DQB1*06:02</italic> negative hypersomnia in this population (<italic>P</italic>-value of 2.51E-02, per-allele OR of 1.25 with 95% CI of 1.03–1.52) (<xref ref-type="table" rid="table-2">Table 2</xref>); these finds were similar to those from the GWAS of Japanese patients with <italic>HLA-DQB1*06:02</italic> negative EHS (<italic>P</italic>-value of 3.43E-06, per-allele OR of 1.52 with 95% CI of 1.13–2.04) (<xref ref-type="table" rid="table-1">Table 1</xref>). To investigate possible contributions of this SNP to other forms of hypersomnia, we tested the association of rs10988217 with narcolepsy with cataplexy in Japanese and Caucasian patients (<xref ref-type="bibr" rid="ref-14">Hallmayer et al., 2009</xref>). Significant associations were observed in Japanese narcolepsy (<italic>P</italic>-value of 2.20E-02, per-allele OR of 1.22 with 95% CI of 1.03–1.45) and Caucasian narcolepsy (<italic>P</italic>-value of 2.82E-02, per-allele OR of 1.13 with 95% CI of 1.01–1.27) (<xref ref-type="table" rid="table-3">Table 3</xref>). Other SNPs that showed associations with an increased risk of EHS in the Japanese population were also genotyped in the samples from Caucasian patients with <italic>HLA-DQB1*06:02</italic> negative hypersomnia, but no associations were found (<xref ref-type="table" rid="table-2">Table 2</xref>).</p>
      <table-wrap id="table-2">
        <object-id pub-id-type="doi">10.7717/peerj.66/table-2</object-id>
        <label>Table 2</label>
        <caption>
          <title>List of SNPs of interest for <italic>HLA-DQB1*06:02</italic> negative hypersomnias samples in Caucasian population.</title>
        </caption>
        <alternatives>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/66/table-2.png"/>
          <table>
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">SNP(A/B)</th>
                <th align="left">Risk allele</th>
                <th align="center" colspan="2">RAF</th>
                <th align="center" colspan="2">HWE <italic>P</italic>-values</th>
                <th align="center" colspan="3">Chi-square 2-tailed <italic>P</italic>-values</th>
                <th align="left">OR</th>
                <th align="left">L95</th>
                <th align="left">U95</th>
                <th align="left">Nearest gene</th>
              </tr>
              <tr>
                <th align="left"/>
                <th align="left"/>
                <th align="left">Control</th>
                <th align="left">Case</th>
                <th align="left">Control</th>
                <th align="left">Case</th>
                <th align="left">Allelic</th>
                <th align="left">Dominant</th>
                <th align="left">Recessive</th>
                <th align="left"/>
                <th align="left"/>
                <th align="left"/>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">rs11854769 (C/T)</td>
                <td align="left">C</td>
                <td align="left">0.731</td>
                <td align="left">0.732</td>
                <td align="left">0.369</td>
                <td align="left">0.263</td>
                <td align="left">9.70E-01</td>
                <td align="left">3.00E-01</td>
                <td align="left">6.20E-01</td>
                <td align="left">1.00</td>
                <td align="left">0.81</td>
                <td align="left">1.23</td>
                <td align="left">
                  <italic>SPRED1</italic>
                </td>
              </tr>
              <tr>
                <td align="left">rs16966290(C/A)</td>
                <td align="left">A</td>
                <td align="left">0.885</td>
                <td align="left">0.903</td>
                <td align="left">0.947</td>
                <td align="left">0.286</td>
                <td align="left">2.30E-01</td>
                <td align="left">7.70E-01</td>
                <td align="left">1.70E-01</td>
                <td align="left">1.20</td>
                <td align="left">0.88</td>
                <td align="left">1.63</td>
                <td align="left">
                  <italic>SPRED1</italic>
                </td>
              </tr>
              <tr>
                <td align="left">rs12471007(C/G)</td>
                <td align="left">G</td>
                <td align="left">0.035</td>
                <td align="left">0.040</td>
                <td align="left">0.179</td>
                <td align="left">0.501</td>
                <td align="left">5.50E-01</td>
                <td align="left">4.40E-01</td>
                <td align="left">4.50E-01</td>
                <td align="left">1.15</td>
                <td align="left">0.72</td>
                <td align="left">1.85</td>
                <td align="left">
                  <italic>NCKAP5</italic>
                </td>
              </tr>
              <tr>
                <td align="left">rs10988217(G/A)</td>
                <td align="left">G</td>
                <td align="left">0.597</td>
                <td align="left">0.648</td>
                <td align="left">0.581</td>
                <td align="left">0.456</td>
                <td align="left">2.51E-02</td>
                <td align="left">3.00E-02</td>
                <td align="left">1.16E-01</td>
                <td align="left">1.25</td>
                <td align="left">1.03</td>
                <td align="left">1.52</td>
                <td align="left">
                  <italic>CRAT</italic>
                </td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="table-2fn">
            <p>
              <bold>Notes.</bold>
            </p>
          </fn>
          <fn id="table-2fn1" fn-type="other">
            <p>RAF: Risk allele frequency, HWE: Hardy-Weinberg Equilibrium, OR: Odds ratio, L95, U95: lower and upper limits of confidence interval at 95%.</p>
          </fn>
          <fn id="table-2fn2" fn-type="other">
            <p>Recessive model is calculated under risk allele homozygotes versus (heterozygous and non-risk homozygotes).</p>
          </fn>
          <fn id="table-2fn3" fn-type="other">
            <p>Dominant model is calculated under (risk allele homozygotes and heterozygotes) versus non-risk homozygotes.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="table-3">
        <object-id pub-id-type="doi">10.7717/peerj.66/table-3</object-id>
        <label>Table 3</label>
        <caption>
          <title>GWAS and comparative studies for rs10988217 in Japanese and Caucasian populations.</title>
        </caption>
        <alternatives>
          <graphic mimetype="image" mime-subtype="png" xlink:href="https://peerj.com/articles/66/table-3.png"/>
          <table>
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
            </colgroup>
            <thead>
              <tr>
                <th align="left">Subjects</th>
                <th align="center" colspan="4">Case count</th>
                <th align="center" colspan="4">Control count</th>
                <th align="center" colspan="2">AF (Case)</th>
                <th align="center" colspan="2">AF (Control)</th>
                <th align="center" colspan="3">Chi-Square 2-tailed <italic>P</italic>-value</th>
                <th align="center">
                  <italic>P</italic>
                  <sub>min</sub>
                </th>
                <th align="left">OR</th>
                <th align="left">L95</th>
                <th align="left">U95</th>
              </tr>
              <tr>
                <th align="left"/>
                <th align="left">GG</th>
                <th align="left">AG</th>
                <th align="left">AA</th>
                <th align="left">Total</th>
                <th align="left">GG</th>
                <th align="left">AG</th>
                <th align="left">AA</th>
                <th align="left">Total</th>
                <th align="left">G</th>
                <th align="left">A</th>
                <th align="left">G</th>
                <th align="left">A</th>
                <th align="left">Allelic</th>
                <th align="left">Dominant</th>
                <th align="left">Recessive</th>
                <th align="left"/>
                <th align="left"/>
                <th align="left"/>
                <th align="left"/>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left">Japanese <italic>HLA-DQB1*06:02</italic> negative EHS GWAS</td>
                <td align="left" style="padding-left:0.55pc;">21</td>
                <td align="left" style="padding-left:0.55pc;">38</td>
                <td align="left" style="padding-left:0.55pc;">66</td>
                <td align="left" style="padding-left:0.55pc;">125</td>
                <td align="left" style="padding-left:0.55pc;">28</td>
                <td align="left">206</td>
                <td align="left">328</td>
                <td align="left" style="padding-left:0.55pc;">562</td>
                <td align="left">0.320</td>
                <td align="left">0.680</td>
                <td align="left">0.234</td>
                <td align="left">0.770</td>
                <td align="left">4.05E-03</td>
                <td align="left">2.55E-01</td>
                <td align="left">3.43E-06</td>
                <td align="left">3.43E-06</td>
                <td align="left">1.52</td>
                <td align="left">1.13</td>
                <td align="left">2.04</td>
              </tr>
              <tr>
                <td align="left">Caucasian <italic>HLA-DQB1*06:02</italic> negative hypersomnia</td>
                <td align="left">108</td>
                <td align="left">126</td>
                <td align="left" style="padding-left:0.55pc;">30</td>
                <td align="left" style="padding-left:0.55pc;">264</td>
                <td align="left">632</td>
                <td align="left">836</td>
                <td align="left">292</td>
                <td align="left">1760</td>
                <td align="left">0.648</td>
                <td align="left">0.352</td>
                <td align="left">0.597</td>
                <td align="left">0.403</td>
                <td align="left">2.51E-02</td>
                <td align="left">3.00E-02</td>
                <td align="left">1.16E-01</td>
                <td align="left">2.51E-02</td>
                <td align="left">1.25</td>
                <td align="left">1.03</td>
                <td align="left">1.52</td>
              </tr>
              <tr>
                <td align="left">Japanese narcolepsy</td>
                <td align="left" style="padding-left:0.55pc;">37</td>
                <td align="left">161</td>
                <td align="left">211</td>
                <td align="left" style="padding-left:0.55pc;">409</td>
                <td align="left" style="padding-left:0.55pc;">92</td>
                <td align="left">590</td>
                <td align="left">878</td>
                <td align="left">1560</td>
                <td align="left">0.287</td>
                <td align="left">0.713</td>
                <td align="left">0.250</td>
                <td align="left">0.750</td>
                <td align="left">2.22E-02</td>
                <td align="left">8.93E-02</td>
                <td align="left">2.20E-02</td>
                <td align="left">2.20E-02</td>
                <td align="left">1.22</td>
                <td align="left">1.03</td>
                <td align="left">1.45</td>
              </tr>
              <tr>
                <td align="left">Caucasian narcolepsy</td>
                <td align="left">439</td>
                <td align="left">503</td>
                <td align="left">151</td>
                <td align="left">1093</td>
                <td align="left">519</td>
                <td align="left">625</td>
                <td align="left">235</td>
                <td align="left">1379</td>
                <td align="left">0.632</td>
                <td align="left">0.368</td>
                <td align="left">0.600</td>
                <td align="left">0.400</td>
                <td align="left">3.89E-02</td>
                <td align="left">2.82E-02</td>
                <td align="left">2.00E-01</td>
                <td align="left">2.82E-02</td>
                <td align="left">1.13</td>
                <td align="left">1.01</td>
                <td align="left">1.27</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="table-3fn">
            <p>
              <bold>Notes.</bold>
            </p>
          </fn>
          <fn id="table-3fn1" fn-type="other">
            <p>AF: allele frequency; OR: Odds Ratio; L95,U95: lower and upper limits of confidence interval at 95%; <italic>P</italic><sub>min</sub>: minimum <italic>P</italic>-value among three genetic models.</p>
          </fn>
          <fn id="table-3fn2" fn-type="other">
            <p>Recessive model is calculated under risk allele homozygotes versus (heterozygous and non-risk homozygotes).</p>
          </fn>
          <fn id="table-3fn3" fn-type="other">
            <p>Dominant model is calculated under (risk allele homozygotes and heterozygotes) versus non-risk homozygotes.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec>
      <title>Discussions</title>
      <p>This study represents the first GWAS designed to identify common genetic variants that are associated with EHS in a Japanese population; 125 individuals with EHS and 562 healthy controls participated in this study. We identified novel candidate regions associated with an increased risk of EHS in this Japanese population.</p>
      <p>Several SNPs located in an intron of <italic>NCKAP5</italic> gene showed associations with an increased risk of EHS in this study. <italic>NCKAP5</italic> variants are reportedly strongly associated genes with bipolar disorder (<xref ref-type="bibr" rid="ref-34">Smith et al., 2009</xref>), attention deficit hyperactivity disorders (<xref ref-type="bibr" rid="ref-19">Lasky-Su et al., 2008</xref>), and multiple sclerosis (<xref ref-type="bibr" rid="ref-3">Baranzini et al., 2009</xref>). Further meta-analysis of combination of schizophrenia and bipolar disorder confirmed the association between <italic>NCKAP5</italic> variants and both schizophrenia and bipolar disorder (<xref ref-type="bibr" rid="ref-36">Wang, Liu &amp; Aragam, 2010</xref>). Currently, the function of <italic>NCKAP5</italic> is unknown.</p>
      <p><italic>SPRED1</italic> was the gene closest to the SNP with the second highest <italic>P</italic>-value by regional based; <italic>SPRED1</italic> is a member of the Sprouty family of proteins and is known to be phosphorylated by a tyrosine kinase in response to several growth factors (<xref ref-type="bibr" rid="ref-9">Cabrita &amp; Christofori, 2008</xref>). Proteins in the <italic>SPRED1</italic> family act as negative regulators of RAS-RAF interactions and of the mitogen-activated protein kinase (MAPK) signaling pathway (<xref ref-type="bibr" rid="ref-7">Brems et al., 2007</xref>). RAS/MAPK signaling has been implicated in the mediation of reversible circadian outputs (<xref ref-type="bibr" rid="ref-37">Williams et al., 2001</xref>) and sleep/wake condition mechanism (<xref ref-type="bibr" rid="ref-12">Evans, 2003</xref>) of the brain. Some narcolepsy without cataplexy patients have been reported to exhibit down-regulation of lumbar cerebrospinal fluid hypocretin-1 level (<xref ref-type="bibr" rid="ref-6">Bourgin, Zeitzer &amp; Mignot, 2008</xref>) and hypothalamic peptides hypocretin/orexin has been reported to contribute to the intrusion of REM sleep behaviors into wakefulness by coordinating the activity of RAS through hypocretin/orexin neuron during waking stage (<xref ref-type="bibr" rid="ref-8">Burlet, Tyler &amp; Leonard, 2002</xref>). Since <italic>SPRED1</italic> is an important component in the RAS pathway, <italic>SPRED1</italic> might play a crucial role in regulating REM sleep behaviors. In addition, germline mutations in genes involved in the RAS pathway lead to neuro-cardio-facial-cutaneous (NCFC) syndromes (ex: neurofibromatosis 1 (NF1, OMIM 162200) (<xref ref-type="bibr" rid="ref-7">Brems et al., 2007</xref>), Noonan syndrome (NS, OMIM 163950), LEOPARD syndrome (LS, OMIM 151100), cardio-facio-cutaneous syndrome (CFC, OMIM 115150), and Costello syndrome (CS, OMIM 218040) (<xref ref-type="bibr" rid="ref-30">Pasmant et al., 2009</xref>)). The SNP rs11854769 was identified in a recent GWAS of bipolar disorder (<xref ref-type="bibr" rid="ref-13">Ferreira et al., 2008</xref>); this finding may indicate that this <italic>SPRED1</italic> variant may confer a genetic predisposition for multiple neuropsychiatric diseases.</p>
      <p>Association studies for rs10988217 in <italic>CRAT</italic> showed significant associations with both EHS and narcolepsy with cataplexy patients. In addition, these associations were observed not only in Japanese but also in Caucasians (<xref ref-type="table" rid="table-3">Table 3</xref>). These results indicated that <italic>CRAT</italic> may be a susceptibility gene for different types of hypersomnias. The eQTL analysis of rs10988217 revealed that the SNP was associated with alterations in the expression of <italic>CRAT</italic> (<xref ref-type="supplementary-material" rid="supp-3">Figs. S3B</xref>, <xref ref-type="supplementary-material" rid="supp-4">S4B</xref>). Besides the <italic>CRAT</italic> association in our study, interestingly, a recent GWAS (<xref ref-type="bibr" rid="ref-26">Miyagawa et al., 2008</xref>) for narcolepsy with cataplexy in a Japanese population identified a significant association between a SNP adjacent to <italic>CPT1B</italic> (carnitine palmitoyltransferase 1B). This SNP is also associated with changes in <italic>CPT1B</italic> expression levels (<xref ref-type="bibr" rid="ref-26">Miyagawa et al., 2008</xref>). Furthermore, a subsequent association study demonstrated an association between <italic>CPT1B</italic> and EHS (<xref ref-type="bibr" rid="ref-23">Miyagawa et al., 2009</xref>). Both CRAT and CPT1B are involved in the β-oxidation of fatty acid. CRAT gene encodes the carnitine acetyltransferase protein, which is a key enzyme in the β-oxidation pathway in mitochondria, peroxisomes, and the endoplasmic reticulum. CRAT is responsible for catalyzing the reversible transfer of acyl compartments groups from an acyl-CoA thioester to carnitine, and this enzyme regulates the ratio of acylCoA/CoA in the subcellular compartments (<xref ref-type="supplementary-material" rid="supp-5">Fig. S5</xref>). CPT1B is the rate-controlling enzyme of long-chain fatty acid β-oxidation in the mitochondria of muscle tissue. CPT1B catalyzes the transport of long-chain fatty acyl-CoAs from the cytoplasm into the mitochondria through the carnitine shuttle (<xref ref-type="supplementary-material" rid="supp-5">Fig. S5</xref>). Deficiency of short-chain acyl-coenzyme A dehydrogenase in a mouse model resulted in slowing of theta frequency during REM sleep (<xref ref-type="bibr" rid="ref-35">Tafti et al., 2003</xref>). Additionally, acetyl-L-carnitine (ALCAR) is a potential treatment for neurological diseases such as Parkinson’s disease (<xref ref-type="bibr" rid="ref-5">Beal, 2003</xref>) and Alzheimer’s disease (<xref ref-type="bibr" rid="ref-28">Montgomery, Thal &amp; Amrein, 2003</xref>); it is also known to restore β-oxidation of fatty acids in the mitochondria and rescued the slow theta frequency in REM sleep of mice lacking short-chain acyl-coenzyme A dehydrogenase (<xref ref-type="bibr" rid="ref-35">Tafti et al., 2003</xref>). Besides, our group has recently reported a clinical trial of oral L-carnitine on narcolepsy with cataplexy and the results suggested that oral L-carnitine can be a promising treatment for narcolepsy with cataplexy (<xref ref-type="bibr" rid="ref-25">Miyagawa et al., 2013</xref>; <xref ref-type="bibr" rid="ref-27">Miyagawa et al., 2011</xref>). On the basis of these reports, the results in our study indicated that the pathophysiology of hypersomnias is associated with metabolic alterations (<xref ref-type="bibr" rid="ref-25">Miyagawa et al., 2013</xref>; <xref ref-type="bibr" rid="ref-27">Miyagawa et al., 2011</xref>).</p>
      <p>For rs10988217 in <italic>CRAT</italic>, the best <italic>p</italic>-values in Japanese EHS and narcolepsy with cataplexy patients were from the recessive model (<xref ref-type="table" rid="table-3">Table 3</xref>). The recessive model was not significant in Caucasian hypersomnia and narcolepsy with cataplexy patients, but the allelic model showed a significant association (<xref ref-type="table" rid="table-3">Table 3</xref>). This might be due to a difference between the populations. In addition, the risk allele (G) for rs10988217 was minor in Japanese but major in Caucasians (<xref ref-type="table" rid="table-3">Table 3</xref>). As another possibility, rs10988217 is not the primary SNP of <italic>CRAT</italic> region. LD of the primary SNP and rs10988217 might be different between Japanese and Caucasian, contributing to the different significant model. Therefore, a further replication study and re-sequencing should be required to overcome the limitations.</p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>In summary, we report associations of <italic>NCKAP5</italic>, <italic>SPRED1</italic>, and <italic>CRAT</italic> variants with <italic>HLA-DQB1*06:02</italic> negative EHS as novel candidate loci that have not been reported in other GWAS. In addition, our results showed that <italic>CRAT</italic> might act as a susceptibility gene for a variety of hypersomnia disorders. Further additional replication is warranted for confirmation of this study.</p>
    </sec>
    <sec sec-type="supplementary-material" id="supplemental-information">
      <title>Supplemental Information</title>
      <supplementary-material id="supp-1" mimetype="image" mime-subtype="jpeg" xlink:href="https://peerj.com/articles/66/Supplementary figure 1.jpg">
        <object-id pub-id-type="doi">10.7717/peerj.66/supp-1</object-id>
        <label>Figure S1</label>
        <caption>
          <title>Q–Q plot of GWAS data from the patients with HLA-DQB1*06:02 negative EHS in the Japanese population. Q–Q plot was plotted based on Conchran–Armitage trend <italic>P</italic>-values after standard quality control (genomic inflation factor λ = 1.008).</title>
        </caption>
      </supplementary-material>
      <supplementary-material id="supp-2" mimetype="image" mime-subtype="jpeg" xlink:href="https://peerj.com/articles/66/Supplementary figure 2_mod.jpg">
        <object-id pub-id-type="doi">10.7717/peerj.66/supp-2</object-id>
        <label>Figure S2</label>
        <caption>
          <title>Manhattan plot of the GWAS data from the Japanese population.</title>
          <p>Manhattan plot was plotted based on <italic>P</italic>-value calculated using the Cochran–Armitage trend test.</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="supp-3" mimetype="application" mime-subtype="pdf" xlink:href="https://peerj.com/articles/66/Supplementary Figure 3.pdf">
        <object-id pub-id-type="doi">10.7717/peerj.66/supp-3</object-id>
        <label>Figure S3</label>
        <caption>
          <p>eQTL analyses were performed based on data from the Sanger Institute GENEVAR project<sup>14</sup>, this expression data is based on three cell types (fibroblast, lymphoblastoid cell line, and T-cell) from 75 unrelated individuals of Western European ancestry. (A) The plot displays the relationship between <italic>SPRED1</italic> gene expression and rs11854769. (B) The plot displays the relationship between <italic>CRAT</italic> gene expression and rs10988217. (C) The plot displays the relationship between <italic>PPP2R4</italic> gene expression and rs10988217.</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="supp-4" mimetype="application" mime-subtype="pdf" xlink:href="https://peerj.com/articles/66/Supplementary Figure 4.pdf">
        <object-id pub-id-type="doi">10.7717/peerj.66/supp-4</object-id>
        <label>Figure S4</label>
        <caption>
          <p>eQTL association analyses were performed based on transcript expression data from the SNPExpress Database; these data were derived from brain samples from 93 individuals of European ancestry (left) and Peripheral Blood Mononuclear Cell (PMBC) sample. (A) The plot displays the relationship between <italic>SPRED1</italic> gene expression and rs11854769. (B) The plot displays the relationship between <italic>CRAT</italic> gene expression and rs10988217. (C) The plot displays the relationship between <italic>PPP2R4</italic> gene expression and rs10988217.</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="supp-5" mimetype="application" mime-subtype="pdf" xlink:href="https://peerj.com/articles/66/Supplementary figure 5.pdf">
        <object-id pub-id-type="doi">10.7717/peerj.66/supp-5</object-id>
        <label>Figure S5</label>
        <caption>
          <title>Fatty acid synthesis, beta-oxidation and carnitine shuttle pathways in relation to <italic>CRAT</italic> and <italic>CPT1B</italic>.</title>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <sec sec-type="additional-information">
      <title>Additional Information and Declarations</title>
      <fn-group content-type="competing-interests">
        <title>Competing Interests</title>
        <fn id="conflict-1" fn-type="con">
          <p>Katsushi Tokunaga is an Academic Editor for PeerJ.</p>
        </fn>
      </fn-group>
      <fn-group content-type="author-contributions">
        <title>Author Contributions</title>
        <fn id="contribution-1" fn-type="con">
          <p><xref ref-type="contrib" rid="author-1">Seik-Soon Khor</xref> and <xref ref-type="contrib" rid="author-2">Taku Miyagawa</xref> conceived and designed the experiments, performed the experiments, analyzed the data, wrote the paper.</p>
        </fn>
        <fn id="contribution-2" fn-type="con">
          <p><xref ref-type="contrib" rid="author-3">Hiromi Toyoda</xref> conceived and designed the experiments, performed the experiments, analyzed the data.</p>
        </fn>
        <fn id="contribution-3" fn-type="con">
          <p><xref ref-type="contrib" rid="author-4">Maria Yamasaki</xref> and <xref ref-type="contrib" rid="author-13">Makoto Honda</xref> conceived and designed the experiments.</p>
        </fn>
        <fn id="contribution-4" fn-type="con">
          <p><xref ref-type="contrib" rid="author-5">Yoshiya Kawamura</xref>, <xref ref-type="contrib" rid="author-6">Hisashi Tanii</xref>, <xref ref-type="contrib" rid="author-7">Yuji Okazaki</xref>, <xref ref-type="contrib" rid="author-8">Tsukasa Sasaki</xref>, <xref ref-type="contrib" rid="author-9">Ling Lin</xref>, <xref ref-type="contrib" rid="author-11">Tom Rico</xref> and <xref ref-type="contrib" rid="author-14">Emmanuel Mignot</xref> contributed reagents/materials/analysis tools.</p>
        </fn>
        <fn id="contribution-5" fn-type="con">
          <p><xref ref-type="contrib" rid="author-10">Juliette Faraco</xref> analyzed the data, contributed reagents/materials/analysis tools.</p>
        </fn>
        <fn id="contribution-6" fn-type="con">
          <p><xref ref-type="contrib" rid="author-12">Yutaka Honda</xref> conceived and designed the experiments, contributed reagents/materials/analysis tools.</p>
        </fn>
        <fn id="contribution-7" fn-type="con">
          <p><xref ref-type="contrib" rid="author-15">Katsushi Tokunaga</xref> conceived and designed the experiments, analyzed the data, contributed reagents/materials/analysis tools.</p>
        </fn>
      </fn-group>
      <fn-group content-type="other">
        <title>Human Ethics</title>
        <fn id="addinfo-1" fn-type="other">
          <p>The following information was supplied relating to ethical approvals (i.e. approving body and any reference numbers):</p>
          <p>All subjects had given written informed consent for their participation in these studies in accordance with the process approved by ethics committees of the University of Tokyo and Stanford University. The approval number for the ethics committees will be 910-(14).</p>
        </fn>
      </fn-group>
    </sec>
    <ref-list content-type="authoryear">
      <title>References</title>
      <ref id="ref-1">
        <label>(2001)</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>American Academy of Sleep Medicine</surname>
              <given-names/>
            </name>
            <name>
              <surname>European Sleep Research Society</surname>
              <given-names/>
            </name>
            <name>
              <surname>Japanese Society of Sleep Research</surname>
              <given-names/>
            </name>
            <name>
              <surname>Latin American Sleep Society</surname>
              <given-names/>
            </name>
          </person-group>
          <source>The international classification of sleep disorders, revised: diagnostic and coding manual</source>
          <edition>2001 edition</edition>
          <year iso-8601-date="2001">2001</year>
          <comment>PDF-complete, Library of Congress Catalog No. 97-71405. Retrieved 2010-08-08</comment>
          <pub-id pub-id-type="other">0-9657220-1-5</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-2">
        <label>American Academy of Sleep Medicine (2005)</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>American Academy of Sleep Medicine</collab>
          </person-group>
          <source>The international classification of sleep disorders: diagnostic and coding manual</source>
          <year iso-8601-date="2005">2005</year>
          <publisher-loc>Westchester</publisher-loc>
          <publisher-name>American Academy of Sleep Medicine</publisher-name>
        </element-citation>
      </ref>
      <ref id="ref-3">
        <label>Baranzini et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baranzini</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gibson</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Galwey</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Naegelin</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Barkhof</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Radue</surname>
              <given-names>EW</given-names>
            </name>
            <name>
              <surname>Lindberg</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Uitdehaag</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Angelakopoulou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Prinjha</surname>
              <given-names>RK</given-names>
            </name>
            <name>
              <surname>Gass</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Geurts</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Kragt</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sombekke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Vrenken</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Qualley</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lincoln</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Gomez</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Caillier</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>George</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Mousavi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Guerrero</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Okuda</surname>
              <given-names>DT</given-names>
            </name>
            <name>
              <surname>Cree</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Waubant</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Goodin</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Pelletier</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Matthews</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Hauser</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Kappos</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Polman</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Oksenberg</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis</article-title>
          <source>Human Molecular Genetics</source>
          <issue>4</issue>
          <year iso-8601-date="2009">2009</year>
          <volume>18</volume>
          <fpage>767</fpage>
          <lpage>778</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddn388</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-4">
        <label>Barrett et al. (2005)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barrett</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Fry</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Maller</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Daly</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Haploview: analysis and visualization of LD and haplotype maps</article-title>
          <source>Bioinformatics</source>
          <issue>2</issue>
          <year iso-8601-date="2005">2005</year>
          <volume>21</volume>
          <fpage>263</fpage>
          <lpage>265</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/bth457</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-5">
        <label>Beal (2003)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beal</surname>
              <given-names>MF</given-names>
            </name>
          </person-group>
          <article-title>Bioenergetic approaches for neuroprotection in Parkinson’s disease</article-title>
          <source>Annals of Neurology</source>
          <year iso-8601-date="2003">2003</year>
          <volume>53</volume>
          <fpage>S39</fpage>
          <lpage>S48</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.10479</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-6">
        <label>Bourgin, Zeitzer &amp; Mignot (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bourgin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zeitzer</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Mignot</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>CSF hypocretin-1 assessment in sleep and neurological disorders</article-title>
          <source>The Lancet Neurology</source>
          <issue>7</issue>
          <year iso-8601-date="2008">2008</year>
          <volume>7</volume>
          <fpage>649</fpage>
          <lpage>662</lpage>
          <pub-id pub-id-type="doi">10.1016/S1474-4422(08)70140-6</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-7">
        <label>Brems et al. (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brems</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Chmara</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sahbatou</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Denayer</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Taniguchi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kato</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Somers</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Messiaen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>De Schepper</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fryns</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Cools</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Marynen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Yoshimura</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Legius</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype</article-title>
          <source>Nature Genetics</source>
          <issue>9</issue>
          <year iso-8601-date="2007">2007</year>
          <volume>39</volume>
          <fpage>1120</fpage>
          <lpage>1126</lpage>
          <pub-id pub-id-type="doi">10.1038/ng2113</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-8">
        <label>Burlet, Tyler &amp; Leonard (2002)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burlet</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tyler</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Leonard</surname>
              <given-names>CS</given-names>
            </name>
          </person-group>
          <article-title>Direct and indirect excitation of laterodorsal tegmental neurons by Hypocretin/Orexin peptides: implications for wakefulness and narcolepsy</article-title>
          <source>The Journal of Neuroscience</source>
          <issue>7</issue>
          <year iso-8601-date="2002">2002</year>
          <volume>22</volume>
          <fpage>2862</fpage>
          <lpage>2872</lpage>
        </element-citation>
      </ref>
      <ref id="ref-9">
        <label>Cabrita &amp; Christofori (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cabrita</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Christofori</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Sprouty proteins, masterminds of receptor tyrosine kinase signaling</article-title>
          <source>Angiogenesis</source>
          <issue>1</issue>
          <year iso-8601-date="2008">2008</year>
          <volume>11</volume>
          <fpage>53</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="doi">10.1007/s10456-008-9089-1</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-10">
        <label>Consortium (2005)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>International Hapmap Consortium</surname>
              <given-names/>
            </name>
          </person-group>
          <article-title>A haplotype map of the human genome</article-title>
          <source>Nature</source>
          <issue>7063</issue>
          <year iso-8601-date="2005">2005</year>
          <volume>437</volume>
          <fpage>1299</fpage>
          <lpage>1320</lpage>
          <pub-id pub-id-type="doi">10.1038/nature04226</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-11">
        <label>Dimas et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dimas</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Deutsch</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stranger</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Montgomery</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Borel</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Attar-Cohen</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ingle</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Beazley</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gutierrez Arcelus</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sekowska</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gagnebin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nisbett</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Deloukas</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dermitzakis</surname>
              <given-names>ET</given-names>
            </name>
            <name>
              <surname>Antonarakis</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>Common regulatory variation impacts gene expression in a cell type-dependent manner</article-title>
          <source>Science</source>
          <issue>5945</issue>
          <year iso-8601-date="2009">2009</year>
          <volume>325</volume>
          <fpage>1246</fpage>
          <lpage>1250</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1174148</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-12">
        <label>Evans (2003)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Evans</surname>
              <given-names>BM</given-names>
            </name>
          </person-group>
          <article-title>Sleep, consciousness and the spontaneous and evoked electrical activity of the brain. Is there a cortical integrating mechanism?</article-title>
          <source>Neurophysiologie Clinique</source>
          <issue>1</issue>
          <year iso-8601-date="2003">2003</year>
          <volume>33</volume>
          <fpage>1</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="doi">10.1016/S0987-7053(03)00002-9</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-13">
        <label>Ferreira et al. (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferreira</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>O’Donovan</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Meng</surname>
              <given-names>YA</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Ruderfer</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kirov</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Perlis</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Green</surname>
              <given-names>EK</given-names>
            </name>
            <name>
              <surname>Smoller</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Grozeva</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nikolov</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Chambert</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hamshere</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Nimgaonkar</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Moskvina</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Thase</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Caesar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sachs</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Franklin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gordon-Smith</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ardlie</surname>
              <given-names>KG</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Fraser</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Blumenstiel</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Defelice</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Breen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gill</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morris</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Elkin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Muir</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>McGhee</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Williamson</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>MacIntyre</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>MacLean</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>St Clair</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Van Beck</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pereira</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Kandaswamy</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>McQuillin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Collier</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Bass</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>AH</given-names>
            </name>
            <name>
              <surname>Lawrence</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ferrier</surname>
              <given-names>IN</given-names>
            </name>
            <name>
              <surname>Anjorin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Farmer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Curtis</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Scolnick</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>McGuffin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Daly</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Corvin</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Holmans</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Blackwood</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Gurling</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Owen</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Purcell</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Sklar</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Craddock</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Consortium</surname>
              <given-names>WTCC</given-names>
            </name>
          </person-group>
          <article-title>Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder</article-title>
          <source>Nature Genetics</source>
          <issue>9</issue>
          <year iso-8601-date="2008">2008</year>
          <volume>40</volume>
          <fpage>1056</fpage>
          <lpage>1058</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.209</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-14">
        <label>Hallmayer et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hallmayer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Faraco</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hesselson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Winkelmann</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kawashima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Plazzi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nevsimalova</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bourgin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Högl</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Longstreth</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Montplaisir</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kemlink</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Einen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Musone</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Akana</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miyagawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Duan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Desautels</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Erhardt</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Hesla</surname>
              <given-names>PE</given-names>
            </name>
            <name>
              <surname>Poli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Frauscher</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SP</given-names>
            </name>
            <name>
              <surname>Ton</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Kvale</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kolesar</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dobrovolná</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nepom</surname>
              <given-names>GT</given-names>
            </name>
            <name>
              <surname>Salomon</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wichmann</surname>
              <given-names>HE</given-names>
            </name>
            <name>
              <surname>Rouleau</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Gieger</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Levinson</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Gejman</surname>
              <given-names>PV</given-names>
            </name>
            <name>
              <surname>Meitinger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Peppard</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Tokunaga</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kwok</surname>
              <given-names>PY</given-names>
            </name>
            <name>
              <surname>Risch</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mignot</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Narcolepsy is strongly associated with the T-cell receptor alpha locus</article-title>
          <source>Nature Genetics</source>
          <issue>6</issue>
          <year iso-8601-date="2009">2009</year>
          <volume>41</volume>
          <fpage>708</fpage>
          <lpage>711</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.372</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-15">
        <label>Heinzen et al. (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heinzen</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Ge</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Cronin</surname>
              <given-names>KD</given-names>
            </name>
            <name>
              <surname>Maia</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Shianna</surname>
              <given-names>KV</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>WN</given-names>
            </name>
            <name>
              <surname>Welsh-Bohmer</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Hulette</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Denny</surname>
              <given-names>TN</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>DB</given-names>
            </name>
          </person-group>
          <article-title>Tissue-specific genetic control of splicing: implications for the study of complex traits</article-title>
          <source>PLoS Biology</source>
          <issue>12</issue>
          <year iso-8601-date="2008">2008</year>
          <volume>6</volume>
          <fpage>e1</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pbio.1000001</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-16">
        <label>Honda et al. (1986)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Honda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Juji</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matsuki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Naohara</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Satake</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Inoko</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Someya</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Harada</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Doi</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy</article-title>
          <source>Sleep</source>
          <issue>1 Pt 2</issue>
          <year iso-8601-date="1986">1986</year>
          <volume>9</volume>
          <fpage>133</fpage>
          <lpage>142</lpage>
        </element-citation>
      </ref>
      <ref id="ref-17">
        <label>Juji et al. (1984)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Juji</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Satake</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Doi</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive</article-title>
          <source>Tissue Antigens</source>
          <issue>5</issue>
          <year iso-8601-date="1984">1984</year>
          <volume>24</volume>
          <fpage>316</fpage>
          <lpage>319</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1399-0039.1984.tb02144.x</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-18">
        <label>Komada et al. (2005)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Komada</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Mukai</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shirakawa</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Difference in the characteristics of subjective and objective sleepiness between narcolepsy and essential hypersomnia</article-title>
          <source>Psychiatry and Clinical Neurosciences</source>
          <issue>2</issue>
          <year iso-8601-date="2005">2005</year>
          <volume>59</volume>
          <fpage>194</fpage>
          <lpage>199</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1440-1819.2005.01357.x</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-19">
        <label>Lasky-Su et al. (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lasky-Su</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Neale</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Franke</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Anney</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Zhou</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Maller</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Vasquez</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Asherson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Buitelaar</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Banaschewski</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ebstein</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gill</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Miranda</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mulas</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Oades</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Roeyers</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Rothenberger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sergeant</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sonuga-Barke</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Steinhausen</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Daly</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Laird</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lange</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Faraone</surname>
              <given-names>SV</given-names>
            </name>
          </person-group>
          <article-title>Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations</article-title>
          <source>American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</source>
          <issue>8</issue>
          <year iso-8601-date="2008">2008</year>
          <volume>147B</volume>
          <fpage>1345</fpage>
          <lpage>1354</lpage>
          <pub-id pub-id-type="doi">10.1002/ajmg.b.30867</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-20">
        <label>Li et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Willer</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Scheet</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Abecasis</surname>
              <given-names>GR</given-names>
            </name>
          </person-group>
          <article-title>MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes</article-title>
          <source>Genetic Epidemiology</source>
          <issue>8</issue>
          <year iso-8601-date="2010">2010</year>
          <volume>34</volume>
          <fpage>816</fpage>
          <lpage>834</lpage>
          <pub-id pub-id-type="doi">10.1002/gepi.20533</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-21">
        <label>Marcadet et al. (1985)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marcadet</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gebuhrer</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Betuel</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Seignalet</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Freidel</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Confavreux</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Billiard</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Dausset</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>DNA polymorphism related to HLA-DR2 Dw2 in patients with narcolepsy</article-title>
          <source>Immunogenetics</source>
          <issue>6</issue>
          <year iso-8601-date="1985">1985</year>
          <volume>22</volume>
          <fpage>679</fpage>
          <lpage>683</lpage>
          <pub-id pub-id-type="doi">10.1007/BF00430317</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-22">
        <label>Mignot et al. (2001)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mignot</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rogers</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Qiu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Okun</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Hohjoh</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Miki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Leffell</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Grumet</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fernandez-Vina</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Risch</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups</article-title>
          <source>The American Journal of Human Genetics</source>
          <issue>3</issue>
          <year iso-8601-date="2001">2001</year>
          <volume>68</volume>
          <fpage>686</fpage>
          <lpage>699</lpage>
          <pub-id pub-id-type="doi">10.1086/318799</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-23">
        <label>Miyagawa et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyagawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kawashima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shimada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tokunaga</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Polymorphism located between CPT1B and CHKB, and HLA-DRB1*1501-DQB1*0602 haplotype confer susceptibility to CNS hypersomnias (essential hypersomnia)</article-title>
          <source>PLoS ONE</source>
          <issue>4</issue>
          <year iso-8601-date="2009">2009</year>
          <volume>4</volume>
          <fpage>e5394</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0005394</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-24">
        <label>Miyagawa et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyagawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kawashima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shimada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tokunaga</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Polymorphism located in TCRA locus confers susceptibility to essential hypersomnia with HLA-DRB1*1501-DQB1*0602 haplotype</article-title>
          <source>Journal of Human Genetics</source>
          <issue>1</issue>
          <year iso-8601-date="2010">2010</year>
          <volume>55</volume>
          <fpage>63</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="doi">10.1038/jhg.2009.118</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-25">
        <label>Miyagawa et al. (2013)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyagawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kawamura</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Obuchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ikesaki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ozaki</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tokunaga</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Effects of oral L-carnitine administration in narcolepsy patients: a randomized, double-blind, cross-over and placebo-controlled trial</article-title>
          <source>PLoS ONE</source>
          <issue>1</issue>
          <year iso-8601-date="2013">2013</year>
          <volume>8</volume>
          <fpage>e53707</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0053707</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-26">
        <label>Miyagawa et al. (2008)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyagawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kawashima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nishida</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Ohashi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shimada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Morishita</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shigeta</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Hong</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Faraco</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>YK</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Okazaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tsuji</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Mignot</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Tokunaga</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Variant between CPT1B and CHKB associated with susceptibility to narcolepsy</article-title>
          <source>Nature Genetics</source>
          <issue>11</issue>
          <year iso-8601-date="2008">2008</year>
          <volume>40</volume>
          <fpage>1324</fpage>
          <lpage>1328</lpage>
          <pub-id pub-id-type="doi">10.1038/ng.231</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-27">
        <label>Miyagawa et al. (2011)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miyagawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Miyadera</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kawashima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Shimada</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Tokunaga</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Abnormally low serum acylcarnitine levels in narcolepsy patients</article-title>
          <source>Sleep</source>
          <issue>3</issue>
          <year iso-8601-date="2011">2011</year>
          <volume>34</volume>
          <fpage>349</fpage>
          <lpage>353</lpage>
        </element-citation>
      </ref>
      <ref id="ref-28">
        <label>Montgomery, Thal &amp; Amrein (2003)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Montgomery</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Thal</surname>
              <given-names>LJ</given-names>
            </name>
            <name>
              <surname>Amrein</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer’s disease</article-title>
          <source>International Clinical Psychopharmacology</source>
          <issue>2</issue>
          <year iso-8601-date="2003">2003</year>
          <volume>18</volume>
          <fpage>61</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1097/00004850-200303000-00001</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-29">
        <label>Mukai et al. (2003)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mukai</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Inoue</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ishii</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Saitoh</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nanba</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Clinical characteristics of essential hypersomnia syndrome</article-title>
          <source>Sleep and Biological Rhythms</source>
          <year iso-8601-date="2003">2003</year>
          <volume>1</volume>
          <fpage>229</fpage>
          <lpage>231</lpage>
          <pub-id pub-id-type="doi">10.1046/j.1446-9235.2003.00047.x</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-30">
        <label>Pasmant et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pasmant</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Sabbagh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hanna</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Masliah-Planchon</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jolly</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Goussard</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ballerini</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Cartault</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Barbarot</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Landman-Parker</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Soufir</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Parfait</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Vidaud</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wolkenstein</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Vidaud</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>France</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
          <article-title>SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype</article-title>
          <source>Journal of Medical Genetics</source>
          <issue>7</issue>
          <year iso-8601-date="2009">2009</year>
          <volume>46</volume>
          <fpage>425</fpage>
          <lpage>430</lpage>
          <pub-id pub-id-type="doi">10.1136/jmg.2008.065243</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-31">
        <label>Pruim et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pruim</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Welch</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Sanna</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Teslovich</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Chines</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Gliedt</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Boehnke</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Abecasis</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Willer</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>LocusZoom: regional visualization of genome-wide association scan results</article-title>
          <source>Bioinformatics</source>
          <issue>18</issue>
          <year iso-8601-date="2010">2010</year>
          <volume>26</volume>
          <fpage>2336</fpage>
          <lpage>2337</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btq419</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-32">
        <label>Purcell et al. (2007)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Purcell</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Neale</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Todd-Brown</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Bender</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Maller</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sklar</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>de Bakker</surname>
              <given-names>PI</given-names>
            </name>
            <name>
              <surname>Daly</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Sham</surname>
              <given-names>PC</given-names>
            </name>
          </person-group>
          <article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>
          <source>The American Journal of Human Genetics</source>
          <issue>3</issue>
          <year iso-8601-date="2007">2007</year>
          <volume>81</volume>
          <fpage>559</fpage>
          <lpage>575</lpage>
          <pub-id pub-id-type="doi">10.1086/519795</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-33">
        <label>Roth (1976)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roth</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Narcolepsy and hypersomnia: review and classification of 642 personally observed cases</article-title>
          <source>Schweiz Arch Neurol Neurochir Psychiatr</source>
          <issue>1</issue>
          <year iso-8601-date="1976">1976</year>
          <volume>119</volume>
          <fpage>31</fpage>
          <lpage>41</lpage>
        </element-citation>
      </ref>
      <ref id="ref-34">
        <label>Smith et al. (2009)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>EN</given-names>
            </name>
            <name>
              <surname>Bloss</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Badner</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Barrett</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Belmonte</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>Berrettini</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Byerley</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Coryell</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Craig</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Edenberg</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Eskin</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Foroud</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gershon</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Greenwood</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Hipolito</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Koller</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Lawson</surname>
              <given-names>WB</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lohoff</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>McInnis</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>McMahon</surname>
              <given-names>FJ</given-names>
            </name>
            <name>
              <surname>Mirel</surname>
              <given-names>DB</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Nievergelt</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Nurnberger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Nwulia</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Paschall</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Potash</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Rice</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Schulze</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Scheftner</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Panganiban</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Zaitlen</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Zandi</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Zöllner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Schork</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Kelsoe</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Genome-wide association study of bipolar disorder in European American and African American individuals</article-title>
          <source>Molecular Psychiatry</source>
          <issue>8</issue>
          <year iso-8601-date="2009">2009</year>
          <volume>14</volume>
          <fpage>755</fpage>
          <lpage>763</lpage>
          <pub-id pub-id-type="doi">10.1038/mp.2009.43</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-35">
        <label>Tafti et al. (2003)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tafti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Petit</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Chollet</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Neidhart</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>de Bilbao</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kiss</surname>
              <given-names>JZ</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Franken</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Deficiency in short-chain fatty acid beta-oxidation affects theta oscillations during sleep</article-title>
          <source>Nature Genetics</source>
          <issue>3</issue>
          <year iso-8601-date="2003">2003</year>
          <volume>34</volume>
          <fpage>320</fpage>
          <lpage>325</lpage>
          <pub-id pub-id-type="doi">10.1038/ng1174</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-36">
        <label>Wang, Liu &amp; Aragam (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>XF</given-names>
            </name>
            <name>
              <surname>Aragam</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder</article-title>
          <source>Schizophrenia Research</source>
          <issue>1–3</issue>
          <year iso-8601-date="2010">2010</year>
          <volume>124</volume>
          <fpage>192</fpage>
          <lpage>199</lpage>
          <pub-id pub-id-type="doi">10.1016/j.schres.2010.09.002</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-37">
        <label>Williams et al. (2001)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Williams</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Bernards</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Field</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sehgal</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>A circadian output in Drosophila mediated by neurofibromatosis-1 and Ras/MAPK</article-title>
          <source>Science</source>
          <issue>5538</issue>
          <year iso-8601-date="2001">2001</year>
          <volume>293</volume>
          <fpage>2251</fpage>
          <lpage>2256</lpage>
          <pub-id pub-id-type="doi">10.1126/science.1063097</pub-id>
        </element-citation>
      </ref>
      <ref id="ref-38">
        <label>Yang et al. (2010)</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Beazley</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Montgomery</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Dimas</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Gutierrez-Arcelus</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stranger</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Deloukas</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Dermitzakis</surname>
              <given-names>ET</given-names>
            </name>
          </person-group>
          <article-title>Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies</article-title>
          <source>Bioinformatics</source>
          <issue>19</issue>
          <year iso-8601-date="2010">2010</year>
          <volume>26</volume>
          <fpage>2474</fpage>
          <lpage>2476</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btq452</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
